Centronuclear Myopathy Clinical Trial
Official title:
Myotubular and Centronuclear Myopathy Patient Registry
The Myotubular and Centronuclear Myopathy Patient Registry (also referred to as the 'MTM and CNM Registry') is an international, patient-reported database specific to these conditions. More details and online registration are available at www.mtmcnmregistry.org.
The Myotubular and Centronuclear Myopathy (MTM & CNM) Patient Registry is managed and operated by the John Walton Muscular Dystrophy Research Centre at Newcastle University, in partnership with the Myotubular Trust, and is part of the TREAT-NMD Neuromuscular Network. The registry has been developed in partnership with a number of leading neuromuscular researchers, and is jointly funded by the Myotubular Trust and Muscular Dystrophy UK. Participants register online and must provide consent before accessing the registry questionnaire. The clinical data and genetic or biopsy reports are provided by the participants and their doctors. The MTM & CNM Registry aims to: - Help identify patients for relevant clinical trials as they become available. - Encourage further research into myotubular and centronuclear myopathy. - Provide researchers with specific patient information to support their research. - Assist doctors and other health professionals by providing them with up-to-date information on managing myotubular and centronuclear myopathy, to help them deliver better standards of care for their patients. The investigators welcome the registration of: - All patients with a myotubular myopathy or centronuclear myopathy diagnosis, which has been confirmed via genetic testing or muscle biopsy. - Any carrier females of x-linked myotubular myopathy, especially if they have manifested myotubular myopathy type symptoms. - Any patient who is deceased, but who had a confirmed diagnosis. This is an online registry and is hosted on the RDRF (Rare Disease Registry Framework) by Murdoch University. More details and online registration are available at www.mtmcnmregistry.org. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04977648 -
Natural History Study of Patients With Centronuclear Myopathies
|
||
| Enrolling by invitation |
NCT05099107 -
Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment
|
N/A | |
| Completed |
NCT03351270 -
Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
|
N/A | |
| Recruiting |
NCT05982119 -
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
|
N/A | |
| Terminated |
NCT04033159 -
Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04743557 -
Early Phase Human Drug Trial to Investigate DYN101 in Participants 2 to 17 Years With Centronuclear Myopathies
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06157268 -
The Natural History and Muscle Fatigability of Patients With Congenital Myopathies.
|
||
| Recruiting |
NCT00272883 -
Molecular and Genetic Studies of Congenital Myopathies
|